Skip to main content

Xyosted News (Page 2)

FDA Approves Xyosted (testosterone enanthate) Injection for Testosterone Replacement Therapy in Adult Males

EWING, N.J., Oct. 01, 2018 (GLOBE NEWSWIRE) – Antares Pharma, Inc. (NASDAQ:ATRS) today announced the approval of Xyosted (testosterone enanthate) injection by the U.S. Food and Drug Administration...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Hypogonadism - Male

Xyosted patient information at Drugs.com